WASHINGTON, D.C. (January 24, 2007) -- Biotech investments and innovative new therapies will be highlighted at the Biotechnology Industry Organization (BIO) CEO & Investor Conference 2007, to be held February 12-14 at the Waldorf=Astoria Hotel in New York City. The meeting is co-hosted by Rodman and Renshaw, Jeffries, and CIBC.
“The BIO CEO & Investor Conference is a prime opportunity for investors and CEOs to meet face to face to discuss breakthroughs in the biotech industry,” stated Jim Greenwood, president and CEO of BIO. “Our CEO Conference also provides a bevy of networking opportunities, issue-oriented plenary sessions, and educational sessions focused on hot technologies, therapeutics and key business issues. It’s going to be a tremendous event.”
The three-day program will offer a number of therapeutic workshops on pertinent topics ranging from biotech investments to new advances in treatments and therapies for a wide range of current health issues. Session topics include:
· Baby Boomers – Where Are the Growth Market Opportunities?
· Autoimmune Disease – Life after TNF
· Next Generation Antibodies and Antibody Technologies
· Clearing the Air with New Respiratory Therapies
· Diabetes: Finding the Sweet Spot – New Approaches to Treating, Monitoring, and Managing Diabetes
· Pandemic Panic – The Current State of Vaccine Research
For a full list of workshops and events at the BIO CEO & Investor Conference, please visit the conference website at http://ceo.bio.org/opencms/ceo/2007/index.jsp.
Advance media registration for the BIO CEO & Investor Conference 2007 is now available online. Registration is complimentary for credentialed members of the news media. To register, please visit https://www.compusystems.com/servlet/ar?evt_uid=349&site=MEDIA Only reporters and editors working full-time for print or broadcast news organizations may register onsite with valid media credentials. All freelancers and online publications must register in advance by Wednesday, February 7, 2007.
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products. www.bio.org
· BIO CEO & Investor Conference
Feb. 12-14, 2007, New York City
· 2007 World Congress on Industrial Biotechnology and Bioprocessing
March 21-24, 2007, Orlando, FL
· BIO International Convention
May 6-9, 2007, Boston, MA